Three wishes for improving clinical drug development in pulmonary fibrosis

Eur Respir J. 2023 Mar 2;61(3):2202355. doi: 10.1183/13993003.02355-2022. Print 2023 Mar.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Drug Development
  • Humans
  • Idiopathic Pulmonary Fibrosis* / drug therapy

Substances

  • GLPG1205